Continuous Forsteo Effective for Case of Severe Hypoparathyroidism

Continuous Forsteo Effective for Case of Severe Hypoparathyroidism

305804

Continuous Forsteo Effective for Case of Severe Hypoparathyroidism

In a woman whose severe hypoparathyroidism did not respond to standard treatment, constant infusion of a lab-engineered form of the parathyroid hormone (PTH) eliminated symptoms and improved her quality of life, a case study from Portugal reports. This medication, called Forsteo (teriparatide) and marketed in the U.S. as Forteo, is an approved therapy for osteoporosis, a condition that causes bones to become weak and brittle. The study, “Continuous Teriparatide Treatment in Chronic Hypoparathyroidism: A Case…

You must be logged in to read/download the full post.